Added to YB: 2025-09-17
Pitch date: 2025-09-14
DXCM [neutral]
DexCom, Inc.
-5.46%
current return
Author Info
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.
Market Cap
$27.1B
Pitch Price
$76.44
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.11
P/E
33.71
EV/Sales
5.69
Sector
Health Care Equipment and Supplies
Category
growth
3 Healthcare Stocks on My Radar - DexCom, Inc.
DXCM (quick overview): CGM leader w/ 95% sensor revenue from razor-blade model, high retention vs competitors. Bear case: Abbott/Medtronic price pressure, GLP-1 drugs may reduce T2 diabetes CGM need. Bull case: low penetration in 100M+ US T2/prediabetic market, intl growth, Stelo OTC expansion.
Read full article (2 min)